Apr. 10, 2008 - Apr. 11, 2008
Now in its fifth year, the annual drug discovery and development convention BioFine Europe offers all attendees the opportunity to learn, develop and grow their businesses in the life science market.
Through 3 conference tracks attendees will learn about new applications in molecular genomics for drug discovery. They will find out how to develop new synthesis technologies for intermediates and APIs, and they will learn about best practice in cluster development through the bringing together of leaders from the pharmaceutical and biotech sectors. By attending the offered workshops, participants will understand how and where to integrate a preparative chromatography step while developing synthetic processes.
The expected number of attendees is in excess of 300 and these influential decision makers need discovery service companies in chemistry and biology plus CMOs and CROs to turn their ideas and technologies into reality. The 2 day BioFine exhibition offers supplier companies to the biotech and pharma markets an excellent platform on which to network and sell their products and services to this highly influential audience.
To download the event prospectus please click here.
Visit also: http://www.sp2.uk.com/biofine/europe/